Ascentage Pharma Corp (AAPG) Sof marja

Ascentage Pharma (AAPG) - korporativ logo

Noyob apoptoz patentlari va ulkan R&D investitsiyalari Ascentage Pharma Group (AAPG) uchun kuchli himoya to'sig'ini yaratadi. Sotuvlardan olingan sof foyda daromadlari ushbu salohiyatni tasdiqlaydi, bunda -229.30 joriy metrika darajasi vazifasini o'taydi. Biroq, test natijalari bo'yicha noaniqlik va mablag'lar yetishmasligi xavflarni keltirib chiqaradi. Muvaffaqiyat qat'iy FDA nazorati ostida AQSh va Xitoyda dori vositalarining tasdiqlanishiga bog'liq.

AAPG: Ascentage Pharma Corp Kompaniyaning sof rentabelligi 25.01.2025 - 19.11.2026

Ascentage (AAPG) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning har tomonlama tahlili:Ascentage Pharma, AAPG
Ascentage Pharma Group International yetakchi tovari

Ascentage Pharma Group (AAPG) kompaniyasida Yan Dapin boshchiligida amalga oshirilayotgan innovatsion saratonga qarshi dori vositalarini ishlab chiqish ko'lami ulkan xarajatlarni talab qiladi, bu esa sof foyda marjasini kapitalni boshqarish samaradorligining asosiy ko'rsatkichiga aylantiradi. Ushbu metrika yakuniy foydaning umumiy daromadga nisbati sifatida hisoblanadi, bu esa investorlarga biznesning operatsion muvaffaqiyatlarni real pul oqimiga aylantirish qobiliyatini baholash va aktivning barqarorligini tasdiqlash imkonini beradi.

Ascentage Pharma Group kimlar bilan raqobatlashadi

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi CGON (CG Oncology Corp)|Sof marja UroGen Pharma (URGN)|Sotuvning sof marjinal rentabelligi Bicara Therapeutics (BCAX)|Sotuvning sof marjinal rentabelligi PSNL (personalis.com)|Sof foyda normasi ERAS|DCTH: Sof foyda bo'yicha sotuv rentabelligi|YmAbs - Kompaniyaning sof rentabelligi|aurabiosciences.com (AURA) - Sof marja|Candel Therapeutics Inc. - Sof foyda normasi|Sof marja Accuray Inc.|Sof marja SELLAS Life Sciences Group SLS|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)